Document Classification

Section Type: RESULTS

Text: Acarbose reduced 1-h breakfast glucose increment (baseline 6. 3 + / - 0. 6, 16-week 3. 5 + / - 0. 6 mmol/l, P < 0. 01) and 1-h glucose level (18. 1 + / - 1. 1 and 14. 5 + / - 1. 3 mmol/l, P < 0. 01), whereas glibenclamide did not (6. 6 + / - 0. 7 vs. 5. 4 + / - 0. 6 mmol/l and 18. 9 + / - 1. 5 vs. 15. 3 + / - 1. 3 mmol/l).